105
Participants
Start Date
June 25, 2019
Primary Completion Date
May 21, 2020
Study Completion Date
July 8, 2020
VP-102 and applicator
In part A, VP-102 will be applied for either 2, 6 or 24 hours with each regimen compared to placebo. For part B, 2 of the regimens from part A will be chosen for Part B with each compared to Placebo. Only 4 arms are actually being studied.
Placebo
The placebo single-use applicator contains the same formulation as the VP-102 applicator but does not contain the active pharmaceutical ingredient cantharidin
The Indiana Clinical Trials Center,PC, Plainfield
Clarkston Skin Research, Clarkston
DelRicht Research, Baton Rouge
DelRicht Research, Tulsa
Collaborators (1)
Instat Consulting, Inc.
OTHER
Paidion Research, Inc.
INDUSTRY
BioClinica, Inc.
INDUSTRY
Verrica Pharmaceuticals Inc.
INDUSTRY